CLGN
Collplant Biotechnologies Ltd
NASDAQ: CLGN · HEALTHCARE · BIOTECHNOLOGY
$0.37
-4.51% today
Updated 2026-04-29
Market cap
$6.00M
P/E ratio
—
P/S ratio
2.53x
EPS (TTM)
$-0.94
Dividend yield
—
52W range
$0 – $5
Volume
0.1M
Collplant Biotechnologies Ltd (CLGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-5,250.00%
ROE
-117.60%
ROA
-48.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-4.46M | — | — | — |
| 2013 | — | $-4.56M | — | — | — |
| 2014 | $0.00 | $-3.64M | — | — | — |
| 2015 | $0.00 | $-4.80M | — | — | — |
| 2016 | $75911.00 | $-7.27M | -196.29% | -9,433.24% | -9,571.91% |
| 2017 | $479917.00 | $-5.80M | 32.85% | -1,244.18% | -1,209.56% |
| 2018 | $4.79M | $-6.25M | 64.99% | -84.91% | -130.50% |
| 2019 | $2.32M | $-11.16M | 2.24% | -329.21% | -481.62% |
| 2020 | $6.14M | $-5.77M | 43.65% | -91.23% | -94.09% |
| 2021 | $15.64M | $237000.00 | 87.18% | 0.42% | 1.52% |
| 2022 | $299000.00 | $-16.93M | -393.65% | -5,718.06% | -5,660.54% |
| 2023 | $10.96M | $-7.02M | 71.78% | -68.55% | -64.05% |
| 2024 | $515000.00 | $-16.61M | -417.09% | -3,349.71% | -3,225.05% |
| 2025 | $2.37M | $-11.49M | 26.32% | -484.31% | -484.56% |